NCT02608047

Brief Summary

The purpose of this study is to elucidate the local epidemic problem and epidemiological characters of dengue fever in Guangzhou, to establish diagnostic and treatment standard and clinical treatment system of severe cases to reduce the morbidity and mortality of dengue fever.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

October 11, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 18, 2015

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2017

Completed
Last Updated

November 18, 2015

Status Verified

November 1, 2015

Enrollment Period

3 years

First QC Date

October 11, 2015

Last Update Submit

November 17, 2015

Conditions

Dengue Fever

Outcome Measures

Primary Outcomes (1)

  • All cause severe dengue

    One year

Study Arms (2)

dengue patients

Dengue patients confirmed by Non-structural protein and RNA

Healthy controls

Healthy population without any diseases

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Dengue patients

You may qualify if:

  • Dengue patients confirmed by dengue virus NS1 or RNA

You may not qualify if:

  • Pregnant women
  • Fever diseases caused by other viruses
  • Combined bacterial infection
  • Without complications such as diabetes and tumor.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guangzhou NO 8. people's hospital

Guangzhou, Guangdong, 510060, China

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Peripheral blood

MeSH Terms

Conditions

Dengue

Condition Hierarchy (Ancestors)

Mosquito-Borne DiseasesVector Borne DiseasesInfectionsArbovirus InfectionsVirus DiseasesFlavivirus InfectionsFlaviviridae InfectionsRNA Virus InfectionsHemorrhagic Fevers, Viral

Study Officials

  • Fuchun Zhang

    Guangzhou NO 8. people's hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Fuchun Zhang, doctor

CONTACT

8620-83710219gz8hzfc@126.com

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice present of hospital

Study Record Dates

First Submitted

October 11, 2015

First Posted

November 18, 2015

Study Start

October 1, 2014

Primary Completion

October 1, 2017

Study Completion

October 1, 2017

Last Updated

November 18, 2015

Record last verified: 2015-11

Locations

CN(1)